Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis

Tuberculosis and Respiratory Diseases

article

Sang Hoon Lee¹  Yoomi Yeo²  Tae-Hyung Kim²  Hong Lyeol Lee³  Jin Hwa Lee⁴  Yong Bum Park⁵  Jong Sun Park⁶  Yee Hyung Kim⁷  Jin Woo Song⁸  Byung Woo Jhun⁹  Hyun Jung Kim^1,10  Jinkyeong Park⁹  Soo-Taek Uh^1,11  Young Whan Kim^1,12  Dong Soon Kim⁸  Moo Suk Park¹ 

[1] Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Institute of Chest Diseases, Yonsei University College of Medicine;Division of Pulmonary and Critical Care Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University College of Medicine;Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Lung Research Institute of Hallym University College of Medicine;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine;Division of Pulmonary and Critical Care Medicine, Kyung Hee University Hospital at Gangdong;Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine;Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine;Department of Internal Medicine, Keimyung University School of Medicine;Department of Internal Medicine, Soonchunhyang University Seoul Hospital;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital

关键词: Idiopathic Pulmonary Fibrosis;    Diagnosis;    Disease Management;    Korea;   

DOI  :  10.4046/trd.2018.0091

学科分类：医学（综合）

来源: The Korean Academy of Tuberculosis and Respiratory Diseases

【 摘 要 】

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea. Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts' help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.

【 授权许可】

CC BY-NC